Milestone Scientific (NYSE:MLSS) Now Covered by StockNews.com

Stock analysts at StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report issued on Sunday. The firm set a “hold” rating on the stock.

Separately, Benchmark restated a “speculative buy” rating and issued a $1.25 price objective on shares of Milestone Scientific in a report on Wednesday, November 20th.

Milestone Scientific Price Performance

NYSE MLSS opened at $0.95 on Friday. The company has a market cap of $74.00 million, a P/E ratio of -13.57 and a beta of 1.10. The stock has a 50-day moving average of $0.83 and a two-hundred day moving average of $0.87. Milestone Scientific has a 1-year low of $0.52 and a 1-year high of $1.10.

Insider Activity at Milestone Scientific

In other Milestone Scientific news, Director Leonard Osser sold 107,984 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total value of $100,425.12. Following the sale, the director now directly owns 4,606,882 shares of the company’s stock, valued at approximately $4,284,400.26. This represents a 2.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. 24.75% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Milestone Scientific

Institutional investors and hedge funds have recently modified their holdings of the company. Geode Capital Management LLC lifted its stake in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after purchasing an additional 31,572 shares during the last quarter. World Investment Advisors LLC acquired a new stake in Milestone Scientific during the third quarter worth approximately $91,000. Finally, Y Intercept Hong Kong Ltd purchased a new stake in shares of Milestone Scientific during the 3rd quarter worth approximately $48,000. Institutional investors and hedge funds own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.